ATRA

Atara Biotherapeutics Inc [NASDAQ: ATRA] jumped around 0.06 points on Firday, while shares priced at $0.76 at the close of the session, up 9.36%. The company report on February 29, 2024 at 9:05 AM that Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus

Atara Biotherapeutics Inc [NASDAQ: ATRA] surged by $0.02 during the normal trading session on while it closed the day at $0.78. The company report on February 29, 2024 at 9:05 AM that Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219,

Atara Biotherapeutics Inc [NASDAQ: ATRA] plunged by -$0.11 during the normal trading session on while it closed the day at $1.11. The company report on January 31, 2024 at 6:30 PM that Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel®